Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Inovio Biomedical Corp (INO)  
$0.58 0.00 (0.00%) as of 4:30 Wed 1/24


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 169,410,000
Market Cap: 97.83(M)
Last Volume: 3,856,623 Avg Vol: 3,846,095
52 Week Range: $0.35 - $0.885
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 5,700 37,076
Total Sell Value $0 $0 $3,192 $60,923
Total People Sold 0 0 1 3
Total Sell Transactions 0 0 1 5
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 505
  Page 14 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kim Jong Joseph Chief Executive Officer   •       •      –    2017-03-30 4 S $6.51 $478,710 D/D (73,590) 2,091,297     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2017-03-30 4 OE $5.08 $373,837 D/D 73,590 2,164,887     -
   Collins Morton Director   –       •      –    2017-03-27 4 B $6.25 $133,189 I/I 21,300 50,000 2.1     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2017-03-10 4 D $6.68 $12,418 D/D (1,859) 85,083     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2017-03-10 4 OE $0.00 $0 D/D 6,077 86,942     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2017-03-10 4 D $6.68 $351,401 D/D (52,605) 2,091,297     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2017-03-10 4 OE $0.00 $0 D/D 139,745 2,143,902     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2017-03-09 4 D $6.61 $50,553 D/D (7,648) 80,865     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2017-03-09 4 OE $0.00 $0 D/D 25,000 88,513     -
   Weiner David B. Director   –       •      –    2017-03-09 4 OE $0.00 $0 D/D 15,334 738,956     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2017-03-09 4 D $6.61 $117,572 D/D (17,787) 2,004,157     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2017-03-09 4 OE $0.00 $0 D/D 57,334 2,021,944     -
   Kies Peter CFO   •       –      –    2017-03-09 4 D $6.61 $60,620 D/D (9,171) 47,048     -
   Kies Peter CFO   •       –      –    2017-03-09 4 OE $0.00 $0 D/D 25,000 56,219     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2017-03-09 4 D $6.61 $50,553 D/D (7,648) 43,110     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2017-03-09 4 OE $0.00 $0 D/D 25,000 50,758     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2017-03-06 4 D $6.95 $21,316 D/D (3,067) 25,758     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2017-03-05 4 OE $0.00 $0 D/D 8,333 28,825     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2017-01-04 4 OE $6.12 $60,056 D/D 9,813 58,247     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2016-08-29 4 S $9.30 $202,733 D/D (21,800) 48,434     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2016-08-28 4 OE $6.12 $202,670 D/D 33,116 70,234     -
   Collins Morton Director   –       •      –    2016-06-28 4 B $9.13 $91,309 D/D 10,000 142,291 2.39     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2016-06-08 4 D $11.24 $1,246,134 D/D (110,866) 1,955,642     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2016-06-08 4 OE $5.08 $1,246,124 D/D 245,300 2,066,508     -
   Benito Simon X Director   –       •      –    2016-05-18 4 S $10.37 $64,819 D/D (6,250) 17,798     -
  505 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 14 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us